Guobang Pharma Ltd. (SHA:605507)

Guobang Pharma Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,647	11,513	9,813	14,792	16,111	-
Market Cap Growth	35.23%	17.32%	-33.66%	-8.19%	-	-
Enterprise Value	10,372	10,267	8,306	12,684	13,589	-
Last Close Price	20.86	20.23	16.76	24.60	26.56	-
PE Ratio	14.69	14.73	16.02	16.06	22.82	-
Forward PE	12.45	10.92	11.33	-	-	-
PS Ratio	1.94	1.95	1.83	2.59	3.58	-
PB Ratio	1.41	1.43	1.32	2.07	2.54	-
P/TBV Ratio	1.47	1.50	1.39	2.18	2.65	-
P/FCF Ratio	115.82	40.07	-	69.15	-	-
P/OCF Ratio	26.85	16.30	18.99	14.54	-	-
EV/Sales Ratio	1.73	1.74	1.55	2.22	3.02	-
EV/EBITDA Ratio	7.97	8.09	8.74	10.48	13.37	-
EV/EBIT Ratio	12.35	12.27	13.20	13.35	16.66	-
EV/FCF Ratio	103.14	35.74	-	59.29	-	-
Debt / Equity Ratio	0.13	0.10	0.13	0.09	0.03	0.28
Debt / EBITDA Ratio	0.81	0.61	1.02	0.55	0.17	0.79
Debt / FCF Ratio	10.47	2.72	-	3.11	-	3.73
Asset Turnover	0.56	0.56	0.55	0.69	0.69	0.82
Inventory Turnover	3.13	3.26	2.98	3.08	2.79	3.05
Quick Ratio	1.57	1.52	1.45	1.93	2.40	0.92
Current Ratio	2.51	2.30	2.22	2.75	3.96	1.46
Return on Equity (ROE)	10.04%	10.08%	8.36%	13.64%	14.68%	27.51%
Return on Assets (ROA)	4.88%	4.95%	4.05%	7.17%	7.83%	12.23%
Return on Capital (ROIC)	5.84%	6.07%	4.85%	8.29%	9.52%	16.11%
Return on Capital Employed (ROCE)	9.70%	10.20%	8.00%	13.20%	12.80%	28.40%
Earnings Yield	6.85%	6.79%	6.24%	6.23%	4.38%	-
FCF Yield	0.86%	2.50%	-2.36%	1.45%	-3.88%	-
Dividend Yield	2.88%	2.96%	1.80%	2.44%	2.63%	-
Payout Ratio	24.09%	24.83%	59.05%	13.92%	47.27%	23.21%
Buyback Yield / Dilution	-1.07%	-0.27%	0.24%	-9.09%	-8.01%	0.28%
Total Shareholder Return	1.81%	2.70%	2.04%	-6.65%	-5.37%	0.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.